通过依赖m6A-YTHDF2的机制抑制NOVA2,METTL14可以逆转肝纤维化

Xiaoxue Hou1, Yuwen Li2, Jiali Song1

  • 1Department of Infectious Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

PubMed
概括

该研究显示,降低METTL14水平通过减少N6-甲基氨酸 (m6A) 修饰,促进HSC激活和NOVA2mRNA降解来恶化肝纤维化. 恢复METTL14或NOVA2可以治疗肝纤维化.